Synapse - Michael Andrew Curran

Michael Andrew Curran

Research Focus

Former Employee. Immunology; Research Associate

Recent additions – View all

Blocking LILRB and KIR receptors by B57 open conformers induces potent antitumor activity and acts synergistically with checkpoint blockade inhibition
Meeting Abstract

Renner, C.; Curran, M. A.; Kolibaba, J.; Liu, Y.; Petrausch, U.; Zippelius, A.; Stenner, F.; Rafiei, A.; Belaunzaran, O. M.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save
Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
Meeting Abstract

Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
Journal for ImmunoTherapy of Cancer (2013)

Fulltext@MSK | Save
Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
Meeting Abstract

Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Co-authors at MSK

10

Allison
3

Montalv...
2

Ariyan
2

Busam
2

Callahan
2

Hollmann
2

Kim
2

Kitano
2

Lesokhin
2

Schaer
2

Wolchok
2

Yuan
1

Cohen
1

Duan
1

Engelhorn
1

Geiger
1

Goldberg
1

Houghton
1

Jenq
1

Kim
1

Kim
1

Lin
1

Liu
1

Merghoub
1

Peggs
1

Quezada
1

Subudhi
1

Sun
1

Terzulli
1

Van Den...

Types of Work

Publications